As of 2026-06-13, the Intrinsic Value of Medtronic PLC (MDT) is 119.06 USD. This Medtronic valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 80.20 USD, the upside of Medtronic PLC is 48.40%.
The range of the Intrinsic Value is 79.46 - 220.86 USD
Based on its market price of 80.20 USD and our intrinsic valuation, Medtronic PLC (MDT) is undervalued by 48.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 79.46 - 220.86 | 119.06 | 48.4% |
| DCF (Growth 10y) | 94.27 - 238.45 | 134.94 | 68.2% |
| DCF (EBITDA 5y) | 90.29 - 103.19 | 96.41 | 20.2% |
| DCF (EBITDA 10y) | 102.43 - 123.52 | 112.35 | 40.1% |
| Fair Value | 31.36 - 31.36 | 31.36 | -60.90% |
| P/E | 93.35 - 130.61 | 114.13 | 42.3% |
| EV/EBITDA | 79.32 - 114.70 | 89.68 | 11.8% |
| EPV | 55.98 - 76.02 | 66.00 | -17.7% |
| DDM - Stable | 36.85 - 106.86 | 71.86 | -10.4% |
| DDM - Multi | 69.80 - 146.36 | 93.39 | 16.4% |
| Market Cap (mil) | 102,967.18 |
| Beta | 0.31 |
| Outstanding shares (mil) | 1,283.88 |
| Enterprise Value (mil) | 129,891.18 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.13% |
| Cost of Debt | 4.39% |
| WACC | 7.13% |